Anika Therapeutics (ANIK) EBT Margin (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly EBT Margin of 10.36% for Q2 2026, up 2442.0% year-over-year from 0.41% in Q2 2025, and up 163.66% quarter-over-quarter from 16.28% in Q1 2026.
Anika Therapeutics (ANIK) EBT Margin (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported EBT Margin for 17 consecutive years, with 10.36% the latest figure, recorded in Q2 2026.
- In Q2 2026, EBT Margin rose 2442.0% year-over-year to 10.36%; the TTM figure through Jun 2026 stood at 3.19% (up 448.0% YoY), while the FY2025 annual figure was 9.08%, down 568.0% from the prior year.
- EBT Margin grew to 10.36% in Q2 2026 per ANIK's latest filing, from 16.28% in the prior quarter.
- Across five years, EBT Margin topped out at 10.36% in Q2 2026 and bottomed at 871.99% in Q4 2023.
- Historically, EBT Margin has averaged 89.71% across 5 years, with a median of 9.19% in 2022.
- Annual changes were most pronounced in 2022 — EBT Margin tumbled 57992 bps — and 2024, when it soared 86782 bps.
- Anika Therapeutics' EBT Margin stood at 598.46% in 2022, then plunged by 46 bps to 871.99% in 2023, then jumped by 100 bps to 4.17% in 2024, then jumped by 86 bps to 0.57% in 2025, then soared by 1903 bps to 10.36% in 2026.
- Business Quant data shows ANIK's EBT Margin at 10.36% in Q2 2026, 16.28% in Q1 2026, and 0.57% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Anika Therapeutics | 284.33 Mn | 245.92 Mn | 21.24 Mn | 10.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.36% |
| Mar 31, 2026 | -16.28% |
| Dec 31, 2025 | -0.57% |
| Sep 30, 2025 | -8.04% |
| Jun 30, 2025 | -14.05% |
| Mar 31, 2025 | -14.79% |
| Dec 31, 2024 | -4.17% |
| Sep 30, 2024 | 1.10% |
| Jun 30, 2024 | -3.95% |
| Mar 31, 2024 | -6.59% |
| Dec 31, 2023 | -871.99% |
| Sep 30, 2023 | -16.98% |
| Jun 30, 2023 | -6.93% |
| Mar 31, 2023 | -31.68% |
| Dec 31, 2022 | -598.46% |
| Sep 30, 2022 | -13.32% |
| Jun 30, 2022 | -8.28% |
| Mar 31, 2022 | -10.11% |
| Dec 31, 2021 | -18.54% |
| Sep 30, 2021 | 3.17% |